Chronic heart failure course prognosis depending on body weight and endogenous intoxication syndrome

Marta O Kondratyuk1, Olena O Sorokopud1, Larysa M Strіl'chuk1

  • 1Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|May 6, 2019
PubMed

Insights

Chronic heart failure (CHF) patients with severe endogenous intoxication and normal body weight have the worst survival rates. Minimizing intoxication and maintaining normal body weight improves outcomes in heart failure patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Biochemistry

Background:

  • Heart failure (CHF) is a prevalent condition with a poor prognosis.
  • Understanding factors influencing CHF complications is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the frequency of complications in CHF patients.
  • To assess the impact of body weight and endogenous intoxication severity on CHF complications.

Main Methods:

  • Clinical examination of 58 CHF patients (41 male, 17 female).
  • Measurement of medium-weight molecules (MWM254) and leptin to assess endogenous intoxication.
  • Randomization into 4 groups based on body mass index and intoxication levels.
  • Statistical analysis using variation statistics software.

Main Results:

  • Worst survival observed in patients with normal body mass and severe endogenous intoxication.
  • Best survival noted with normal body mass and minimal endogenous intoxication.
  • Inverse correlation found between body mass index and blood MWM levels.
  • Elevated leptin associated with hypertension, hyperglycemia, and dyslipidemia.

Conclusions:

  • Increased blood medium-weight molecules (MWM) worsen CHF prognosis.
  • Hypoleptinemia combined with severe endogenous intoxication leads to unfavorable outcomes in CHF patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
822
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
757
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
292
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
862
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
242